Bio-Rad Laboratories Inc Strategic Asset Allocation Index

Latest as of June 2026: 79.8%

Bio-Rad Laboratories Inc strategic asset allocation index. Bio-Rad Laboratories Inc (BIO) has a Strategic Asset Allocation Index of 79.8% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $5.72 Billion) total $5.72 Billion, measured against net assets of $7.17 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Bio-Rad Laboratories Inc balance sheet independence to measure how much of total assets are equity-financed.

SAAI

79.8%
Strategic Assets / Net Assets

Strategic Assets

$5.72 Billion
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$7.17 Billion
USD

Strategic Asset Allocation Index of Bio-Rad Laboratories Inc (2000–2025)

Strategic asset allocation index of Bio-Rad Laboratories Inc from 2000 to 2025. This chart shows how Bio-Rad Laboratories Inc's Strategic Asset Allocation Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 79.8%, representing strategic assets of $5.72 Billion against net assets of $7.17 Billion USD. Check Bio-Rad Laboratories Inc (BIO) tangible net worth to evaluate the tangible quality of the company's equity base.

Bio-Rad Laboratories Inc Strategic Asset Allocation Index by Year (2000–2025)

Bio-Rad Laboratories Inc strategic asset allocation index by year from 2000 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Bio-Rad Laboratories Inc from 2000 to 2025, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BIO stock market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 91.4% $6.81 Billion $709.90 Million $6.10 Billion $7.45 Billion ▲ +7.3 pp
2024 84.1% $5.53 Billion $688.60 Million $4.84 Billion $6.57 Billion ▼ -12.2 pp
2023 96.3% $8.42 Billion $723.74 Million $7.70 Billion $8.74 Billion ▼ -0.7 pp
2022 97.0% $9.33 Billion $498.61 Million $8.83 Billion $9.62 Billion ▼ -13.2 pp
2021 110.2% $15.08 Billion $695.75 Million $14.39 Billion $13.69 Billion ▲ +8.5 pp
2020 101.7% $10.05 Billion $491.37 Million $9.56 Billion $9.88 Billion ▲ +12.5 pp
2019 89.3% $5.14 Billion $499.34 Million $4.64 Billion $5.76 Billion ▲ +10.6 pp
2018 78.7% $3.16 Billion $508.69 Million $2.66 Billion $4.02 Billion ▲ +26.8 pp
2017 51.9% $1.52 Billion $493.50 Million $1.03 Billion $2.93 Billion ▲ +0.8 pp
2016 51.2% $1.32 Billion $488.61 Million $830.79 Million $2.58 Billion ▲ +4.7 pp
2015 46.5% $1.16 Billion $437.69 Million $719.84 Million $2.49 Billion ▲ +9.0 pp
2014 37.4% $818.14 Million $428.84 Million $389.31 Million $2.19 Billion ▲ +0.5 pp
2013 36.9% $807.23 Million $429.36 Million $377.87 Million $2.19 Billion ▲ +16.2 pp
2012 20.7% $416.94 Million $416.94 Million $- $2.02 Billion ▲ +0.7 pp
2011 20.0% $349.50 Million $349.50 Million $- $1.74 Billion ▲ +18.8 pp
2010 1.2% $18.46 Million $18.46 Million $- $1.54 Billion ▼ -22.4 pp
2009 23.6% $302.42 Million $302.42 Million $- $1.28 Billion ▼ -4.4 pp
2008 28.1% $300.73 Million $300.73 Million $- $1.07 Billion ▲ +0.1 pp
2007 27.9% $271.56 Million $271.56 Million $- $971.69 Million ▲ +4.8 pp
2006 23.1% $189.63 Million $189.63 Million $- $819.54 Million ▼ -4.3 pp
2005 27.4% $180.26 Million $180.26 Million $- $657.97 Million ▼ -6.5 pp
2004 33.9% $202.32 Million $202.32 Million $- $596.89 Million ▼ -2.2 pp
2003 36.1% $179.12 Million $179.12 Million $- $495.81 Million ▼ -1.0 pp
2002 37.1% $142.24 Million $142.24 Million $- $383.09 Million ▼ -9.7 pp
2001 46.8% $132.97 Million $132.97 Million $- $283.88 Million ▼ -1.8 pp
2000 48.7% $119.03 Million $119.03 Million $- $244.62 Million —
pp = percentage points